Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Limiting the impact on Kiwis as API leaves the NZ market

Pharmac is working hard to limit the impact on over 1 million Kiwis who currently take funded API Consumer Brands (API) medicines, following their announcement that they are leaving the New Zealand market.

API announced in July this year they are closing their Auckland manufacturing plant and withdrawing from the New Zealand pharmaceutical market in 2022/23. API supplies around 21 funded medicines in New Zealand, including treatments used to manage pain, epilepsy, ADHD, and skin irritations.

This week, Pharmac has signalled to pharmaceutical suppliers it is looking for new suppliers for medicines currently supplied by API. Pharmac is considering multiple options to secure products presently supplied by API. This may mean some of these medicines are included in Pharmac’s Annual Invitation to Tender which is due to be issued in November.

“We want to ensure, first and foremost, that patients can continue to access funded medicines. However, this is going to mean that some people will need to change treatments,” says Pharmac’s director of operations Lisa Williams.

“We are working closely with suppliers, patient advocacy groups, healthcare professionals and other key stakeholders to make any changes as easy as possible for patients. We are committed to ensuring people currently using API’s medicines know about any change before it happens,” says Lisa.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


Commerce Commission: Mercury Cleared To Acquire Trustpower’s Retail Business

The Commerce Commission has granted clearance for Mercury NZ Limited to acquire Trustpower Limited’s retail business. Deputy Chair Sue Begg said the Commission is satisfied that the acquisition is unlikely to substantially lessen competition in any New Zealand market.... More>>



Consumer NZ: Buy-now, Pay-later Raking In $10m+ In Late Fees Annually

A Consumer NZ survey has found buy-now, pay-later services are costing shoppers more than $10 million a year in late fees. Close to four out of 10 Kiwi consumers use buy-now, pay-later services, such as Afterpay, Laybuy and Zip... More>>

Westpac: Catherine Mcgrath Appointed New Zealand CEO

Westpac Group CEO Peter King and the Westpac New Zealand Board today announced the appointment of Catherine McGrath as Chief Executive Officer, Westpac New Zealand... More>>


Statistics: Surge In Imports Results In Record Monthly Trade Deficit
Imports increased $1.8 billion in August 2021 compared with August 2020, resulting in a record monthly trade deficit of $2.1 billion, Stats NZ said today. Exports were little changed, down $42 million. "This is a larger deficit than normal because of higher values for imports.. More>>

Fonterra: Completes reset, announces annual results and long-term growth plan out to 2030

Fonterra Co-operative Group Limited today announced a strong set of results for the 2021 financial year, reflected in a final Farmgate Milk Price of $7.54, normalised earnings per share of 34 cents and a final dividend of 15 cents... More>>


Statistics: GDP rises in the June 2021 quarter

Gross domestic product (GDP) rose by 2.8 percent in the June 2021 quarter, following a 1.4 percent increase in the March 2021 quarter, Stats NZ said today. June 2021 quarter GDP was 4.3 percent higher when compared with the December 2019 quarter... More>>